BioPharma Dive - Latest News

Biotech startup pulls in $187M to make ‘multi-payload’ ADCs

Callio Therapeutics is launching with an ADC technology and programs licensed from Singapore-based antibody drug developer Hummingbird Bioscience.

Mar 3, 2025 - 18:08
 0
Biotech startup pulls in $187M to make ‘multi-payload’ ADCs

Callio Therapeutics is launching with an ADC technology and programs licensed from Singapore-based antibody drug developer Hummingbird Bioscience.

Read More

Tags:

Previous Article

‘Two-Year-Olds Must Carry Their Own Bags!’ American Airlines Gate Agent’s Fake R...

Next Article

STAT+: How DOGE is hitting CMS, and another go with transparency

Related Posts

Vertex challenger Sionna prices $191M IPO

Vertex challenger Sionna prices $191M IPO

Feb 9, 2025  0

Sanofi to take $250M charge on study failure for E. Coli vaccine

Sanofi to take $250M charge on study failure for E. Col...

Feb 13, 2025  0

Beyond copays: Redefining assistance for those with rare diseases and chronic conditions

Beyond copays: Redefining assistance for those with rar...

Feb 18, 2025  0